ORIONS Money Stocks

[sigsmoke]

$BDSI-8x34 cross
80% of shares held by institutes and mutual funds. Upcoming PDUFA Oct. 23rd for Belbuca, the company's treatment for moderate to severe chronic pain. The treatment is made in collaboration with Endo International. Has had 2 positive phase III trials. An approval of BELBUCA would trigger a $50 million milestone payment from Endo to BioDelivery and, upon commercialization, would initiate royalty in mid- to high-teens.